WO2010000569A2 - Agents de conditionnement capillaire contenant des imidazolines - Google Patents

Agents de conditionnement capillaire contenant des imidazolines Download PDF

Info

Publication number
WO2010000569A2
WO2010000569A2 PCT/EP2009/057038 EP2009057038W WO2010000569A2 WO 2010000569 A2 WO2010000569 A2 WO 2010000569A2 EP 2009057038 W EP2009057038 W EP 2009057038W WO 2010000569 A2 WO2010000569 A2 WO 2010000569A2
Authority
WO
WIPO (PCT)
Prior art keywords
group
hair
weight
carbon atoms
preferred
Prior art date
Application number
PCT/EP2009/057038
Other languages
German (de)
English (en)
Other versions
WO2010000569A3 (fr
Inventor
Marcus Krueger
Dieter Goddinger
Original Assignee
Henkel Ag & Co. Kgaa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Henkel Ag & Co. Kgaa filed Critical Henkel Ag & Co. Kgaa
Priority to EP09772269A priority Critical patent/EP2340012A2/fr
Publication of WO2010000569A2 publication Critical patent/WO2010000569A2/fr
Publication of WO2010000569A3 publication Critical patent/WO2010000569A3/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A61K8/4946—Imidazoles or their condensed derivatives, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/41—Amines
    • A61K8/416—Quaternary ammonium compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/42—Amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/004—Preparations used to protect coloured hair
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/12—Preparations containing hair conditioners
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/02—Preparations for cleaning the hair
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/10—Preparations for permanently dyeing the hair

Definitions

  • the invention relates to hair treatment compositions containing cationic imidazolines and amidoamines and the use of these agents for the treatment of skin and hair.
  • Quaternary ammonium compounds of the mono-, di- and / or trialkylammonium type have been known for a long time.
  • a disadvantage of these compounds is their lack of biodegradability. Therefore, cationic compounds containing at least one ester group, the so-called ester quats, have been developed. These, however, show a sensation of being unpleasantly dull in terms of the feel and feel of wet skin and hair as well as the touch and feel of the rewashed skin or hair, which is also perceived as "squeaky” audible.
  • Cationic imidazolines are known to the person skilled in the art as a further class of cationic surfactants, for example from International Publication WO 2006/012930. However, the imidazolines are not able to convince in all properties expected of a hair care agent.
  • cationic imidazolines of the formula I in particular those which have a chain length of the radical R of at least 18 C atoms, preferably 20 C atoms, particularly preferably 21 C atoms, in combination with at least one amine and / or a quaternized amine, especially at least one amidoamine and / or a cationized amidoamine meet the requirements of hair care compositions in an excellent manner.
  • a first subject of the present invention is therefore a composition for the treatment of keratinic fibers, comprising a) at least 0.01% by weight of a quaternary imidazoline derivative having at least two long fatty residues according to the formula I and b) at least 0.01% by weight of an amine and / or a cationized amine, in particular an amidoamine and / or a cationized amidoamine, and c) a cosmetic carrier.
  • compositions according to the invention contain an active ingredient combination of at least two constituents, the constituents a) and b) being used within a certain weight ratio to one another.
  • the weight ratio of imidazoline derivatives a) of the formula I to one of the other cationic compounds b) is 50: 1 to 1:10, preferably 20: 1 to 1:10, more preferably 5: 1 to 1: 5 and in particular 2 , 5: 1 to 1: 2.5.
  • Hair treatment compositions for the purposes of the present invention are, for example, hair dyes, bleaching agents, hair shampoos, hair conditioners, conditioning shampoos, hair sprays, hair rinses, hair treatments, hair wraps, hair tonics, perming solutions, hair dye shampoos, hair dyes, hair fixatives, hair dressings, hair styling preparations, hair lotions , Mousse, hair gels, hair waxes or combinations thereof.
  • Preferred agents according to the invention are shampoos, conditioners or hair tonics.
  • combing is understood according to the invention both the combability of the wet fiber, and the combability of the dry fiber. As a measure of the combing used the combing work or the force used during the combing process of a fiber collective. The measurement parameters can be assessed by the skilled person or quantified by measuring devices.
  • the grip defines the tactility of a fiber collective, whereby the expert sensoryly senses and evaluates the parameters fullness and suppleness of the collective.
  • Shaping is understood to mean the ability to give a shape change to a group of previously treated keratin-containing fibers, in particular human hair. Hair cosmetics also speak of hair styling.
  • an oxidative cosmetic agent containing at least one oxidizing agent on hair in a cosmetic carrier is defined according to the invention.
  • Suitable cosmetic vehicles according to the invention are in particular O / W, W / O and W / O / W emulsions in the form of creams or gels or surfactant-containing foaming solutions, such as shampoos, foam aerosols or other preparations which are especially suitable for use are suitable on the hair.
  • the cosmetic carriers may in particular be aqueous or aqueous-alcoholic.
  • An aqueous cosmetic carrier contains at least 50% by weight of water.
  • aqueous-alcoholic cosmetic carriers include aqueous solutions containing from 3 to 70% by weight of a C 1 -C 6 -alkoxy, in particular methanol, ethanol or propanol, isopropanol, butanol, isobutanol, tert-butanol, n-pentanol, iso-pentanols, n-hexanol, iso-hexanols, glycol, glycerol, 1, 2-pentanediol, 1, 5-pentanediol, 1, 2-hexanediol or 1, 6-hexanediol to understand.
  • the compositions according to the invention may additionally contain further organic solvents, for example methoxybutanol, benzyl alcohol, ethyl diglycol or 1,2-propylene glycol. Preference is given to all water-soluble organic solvents.
  • the agents according to the invention contain at least one quaternary imidazoline compound, i. a compound having a positively charged imidazoline ring.
  • the formula I shown below shows the structure of these compounds.
  • the radicals R are each independently a saturated or unsaturated, linear or branched hydrocarbon radical having a chain length of 18 to 30 carbon atoms.
  • the preferred compounds of the formula I each contain the same hydrocarbon radical for R.
  • the chain length of the radicals R is at least 18 carbon atoms. Preference is given to compounds having a chain length of at least 19 Carbon atoms and more preferably having at least 20 carbon atoms.
  • a very particularly preferred compound of the formula I has a chain length of 21 carbon atoms. A commercial product of this chain length is known, for example, under the name Quaternium-91.
  • the counterions also include the halides, such as chloride, fluoride, bromide, or else phosphates.
  • the imidazolines of the formula I are present in the compositions according to the invention in amounts of from 0.01 to 20% by weight, preferably in amounts of from 0.01 to 10% by weight and very particularly preferably in amounts of from 0.1 to 7.5% by weight. % contain. The very best results are obtained with amounts of from 0.1 to 5% by weight, based in each case on the total composition of the particular agent.
  • the agents according to the invention comprise an amine and / or cationized amine, in particular an amidoamine and / or a cationized amidoamine with the following
  • R 2, R 3 and R 4 are each, independently of one another, hydrogen or an alkyl radical having 1 to 4 C
  • Atoms which may be the same or different, saturated or unsaturated, and
  • X is an anion and n is an integer between 1 and 10.
  • the anion is selected from the physiologically acceptable anions.
  • these are the halide ions, fluoride, chloride, bromide, sulfate of the general formula RSO 3 " , wherein R is the
  • saturated or unsaturated alkyl radicals having 1 to 4 carbon atoms or anionic organic acid radicals such as maleate, fumarate, oxalate, tartrate, citrate, lactate or acetate.
  • composition in which the amine and / or the quaternized amine according to general formulas (Tkat7) and / or (Tkat ⁇ ) is an amidoamine and / or a quaternized
  • Amidoamine is where R1 is a branched or unbranched, saturated or unsaturated
  • Oils and waxes is. Examples include lanolin, bees or candellila waxes in
  • alkylamidoamines are usually made by amidation of natural or synthetic
  • R 2 is the meaning of alkyl radicals having 1 to 4 carbon atoms, hydroxyethyl or hydrogen.
  • the preferred size of n in the general formulas (Tkat7) and / or (Tkat ⁇ ) is an integer between 2 and 5.
  • the alkyl radical having 1 to 4 carbon atoms of R 2, R 3 and R 4 and / or the alkyl radical having 1 to 4 carbon atoms of RSO 3 " in the general formula (Tkat7) and / or (Tkat ⁇ ) may contain at least one hydroxyl group.
  • amidoamines to be used according to the invention are, for example, amidoamines: Witcamine 100 (Witco, INCI name: Cocamidopropyl Dimethylamine), Incromine BB (Croda, INCI name: behenamidopropyl dimethylamine), Mackin 401 (McIntyre, INCI name: isostearylamidopropyl dimethylamine) and other Mackine types, Adogen S1 ⁇ V (Witco, INCI name: Stearylamidopropyl Dimethylamine), and as permanent cationic aminoamines: Rewoquat RTM 50 (Witco Surfactants GmbH, INCI name: Ricinoleamidopropyltrimonium Methosulfate), Empigen CSC (Albright & Wilson, INCI name: Cocamidopropyltrimonium chloride), Swanol Lanoquat DES-50 (Nikko, INCI name: Quatemium-33), Rewoquat
  • amidoamines or quaternized amidoamines according to the general formulas (Tkat7) and (Tkat ⁇ ) can be used individually or in any desired combinations with each other, amounts of from 0.01 to 20% by weight, preferably from 0.01 to 10% by weight. and most preferably in amounts of from 0.1 to 7.5% by weight. The very best results are obtained with amounts of from 0.1 to 5% by weight, based in each case on the total composition of the particular agent.
  • compositions according to the invention preferably contain at least one silicone polymer selected from the group of dimethiconols and / or the group of amino-functional silicones and / or the group of dimethicones and / or the group of cyclomethicones.
  • the dimethicones according to the invention can be both linear and branched as well as cyclic or cyclic and branched.
  • Linear dimethicones can be represented by the following structural formula
  • the radicals R 1 and R 2 are each independently hydrogen, a methyl radical, a C 2 to C 30 linear, saturated or unsaturated hydrocarbon radical, a phenyl radical and / or an aryl radical.
  • the groups represented by R 1 and R 2 include alkyl groups such as methyl, ethyl, propyl, isopropyl, butyl, isobutyl, pentyl, isopentyl, neopentyl, amyl, isoamyl, hexyl, isohexyl and the like; Alkenyl radicals such as vinyl, halovinyl, alkylvinyl, allyl, haloallyl, alkylallyl; Cycloalkyl radicals such as cyclobutyl, cyclopentyl, cyclohexyl and the like; Phenyl radicals, benzyl radicals, halohydrocarbon radicals such as 3-chloropropyl, 4-
  • R 1 examples include methylene, ethylene, propylene, hexamethylene, decamethylene, -CH 2 CH (CH 3 ) CH 2 -, phenylene, naphthylene, -CH 2 CH 2 SCH 2 CH 2 -, -CH 2 CH 2 OCH 2 - , -OCH 2 CH 2 -, -OCH 2 CH 2 CH 2 -, -CH 2 CH (CH 3 ) C (O) OCH 2 -, - (CH 2 ) 3 CC (O) OCH 2 CH 2 -, C 6 H 4 C 6 H 4 -, -C 6 H 4 CH 2 C 6 H 4 -; and - (CH 2 ) 3 C (O) SCH 2 CH 2 -.
  • R 1 and R 2 are methyl, phenyl and C 2 to C 22 alkyl radicals. Of the C2 to C22 alkyl radicals, lauryl, stearyl and behenyl radicals are particularly preferred.
  • the numbers x, y and z are integers and each run independently from 0 to 50,000.
  • the molecular weights of Dimethicone lie between 1,000 D and 10000000 D.
  • the viscosities are between 100 and 10,000,000 cPs measured at 25 0 C by means of a glass capillary viscometer according to Dow Corning Corporate Test Method CTM 0004 dated 20 July 1970. Preferred viscosities are 1000-5000000 cPs, most preferred viscosities are between 10,000 and 3,000,000 cps.
  • the most preferred range is between 50,000 and 2,000,000 cps. Most preferred are viscosities around the range of about 60,000 cps.
  • the word "about” defines a deviation from the stated value following the word “about” which is customary in the art for technically manufactured products. By way of example, reference may be made here to the product "Dow Corning 200 with 6000 OcSt.”
  • the dimethicones (Sil) are present in the compositions according to the invention in amounts of 0.01 to 10% by weight, preferably 0.01 to 8% by weight, particularly preferably 0 , 1 to 7.5 wt.% And in particular 0.1 to 5 wt.% Based on the total composition.
  • Particularly preferred agents according to the invention contain one or more amino-functional silicones. Such silicones may be represented, for example, by the formula (Si-2)
  • R is a hydrocarbon or a hydrocarbon radical having from 1 to about 6
  • Q is a polar radical of the general formula -R 1 HZ, wherein
  • R 1 is a divalent linking group bonded to hydrogen and the radical Z composed of carbon and hydrogen atoms, carbon, hydrogen and oxygen atoms or carbon, hydrogen and nitrogen atoms, and
  • Z is an organic, amino-functional group containing at least one amino-functional group; a assumes values in the range of about 0 to about 2, b takes values in the range of about 1 to about 3, a + b is less than or equal to 3, and c is a number in the range of about 1 to about 3, and x a number ranging from 1 to about 2,000, preferably from about 3 to about 50, and most preferably from about 3 to about 25; and y is a number ranging from about 20 to about 10,000, preferably from about 125 to about 10,000 and most preferably from about 150 to about 1000, and M is a suitable silicone end group as known in the art, preferably trimethylsiloxy.
  • Non-limiting examples of the groups represented by R in formula (Si-2) include alkyl groups such as methyl, ethyl, propyl, isopropyl, isopropyl, butyl, isobutyl, amyl, isoamyl, hexyl, isohexyl and the like; Alkenyl radicals such as vinyl, halovinyl, alkylvinyl, allyl, haloallyl, alkylallyl; Cycloalkyl radicals such as cyclobutyl, cyclopentyl, cyclohexyl and the like; Phenyl radicals, benzyl radicals, halohydrocarbon radicals such as 3-chloropropyl, 4-bromobutyl, 3,3,3-trifluoropropyl, chlorocyclohexyl, bromophenyl, chlorophenyl and the like, and sulfur-containing radicals such as mercaptoethyl, mer
  • R 1 examples include methylene, ethylene, propylene, hexamethylene, decamethylene, - CH 2 CH (CH 3 ) CH 2 -, phenylene, naphthylene, -CH 2 CH 2 SCH 2 CH 2 -, -CH 2 CH 2 OCH 2 - , -OCH 2 CH 2 -, - OCH 2 CH 2 CH 2 -, -CH 2 CH (CH 3 ) C (O) OCH 2 -, - (CHz) 3 CC (O) OCH 2 CH 2 -, -C 6 H 4 C 6 H 4 -, -C 6 H 4 CH 2 C 6 H 4 -; and - (CH 2 ) 3 C (O) SCH 2 CH 2 -.
  • Z is according to formula (Si-2) an organic, amino-functional radical containing at least one functional amino group.
  • a possible formula for said Z is NH (CH 2 ) z NH 2 , where z is an integer greater than or equal to one.
  • Another possible formula for said Z is -NH (CH 2 ) Z (CH 2 ) zz NH, wherein both z and zz independently of one another are an integer greater than or equal to 1, this structure comprising diamino ring structures, such as piperazinyl.
  • Said Z is most preferably an -NHCH 2 CH 2 NH 2 radical.
  • Z is - N (CH 2 ) Z (CH 2 ) ZZ NX 2 or -NX 2 , wherein each X of X 2 is independently selected from the group consisting of hydrogen and alkyl groups of 1 to 12 carbon atoms, and zz is 0.
  • Q according to formula (Si-2) is most preferably a polar amino-functional radical of formula - CH 2 CH 2 CH 2 NH 2 CH 2 CH 2 NH 2 .
  • ⁇ assumes values in the range of 0 to 2
  • b takes values in the range of 2 to 3
  • a + b is less than or equal to 3
  • c is a number in the range of 1 to 3.
  • the molar ratio of the R a Q b SiO (4 a a b) / 2 units to the R 0 SiO (4 C) / 2 units in formula (Si-2) is in the range of about 1: From 2 to 1: 65, preferably from about 1: 5 to about 1:65, and most preferably from about 1:15 to about 1: 20. If one or more of the above formula (Si-2) silicones are used then the various variable substituents in the above formula may be different for the various silicone components present in the silicone blend.
  • Preferred cosmetic or dermatological preparations of the invention contain an amino-functional silicone of the formula (Si-3), R 'a G 3 - a -Si (OSiG 2) n - (OSiG b R' 2 _ b) m -O-SiG 3 - a - R 'a (Si-3), wherein means:
  • G is -H, a phenyl group, -OH, -O-CH 3 , -CH 3 , -O-CH 2 CH 3 , -CH 2 CH 3 , -O-CH 2 CH 2 CH 3 ,
  • 20 -alkyl radicals preferably -CH 3 , -CH 2 CH 3 , -CH 2 CH 2 CH 3 , -CH (CH 3 ) 2 , -CH 2 CH 2 CH 2 CH 3 , -CH 2 CH (CH 3 ) 2 , -CH (CH 3 ) CH 2 CH 3 , -C (CH 3 J 3 , and A represents an anion, which is preferably selected from chloride, bromide, iodide or methosulfate.
  • Cationic silicone oils such as the commercially available Dow Corning 929 emulsion (containing a hydroxylamino-modified silicone referred to as amodimethicone), DC 2-2078 (manufacturer Dow Corning, INCI name: Aminopropyl Phenyl Trimethicone), DC 5 are suitable according to the invention -7113 (manufacturer Dow Corning, INCI name: Silicone Quaternium 16), SM-2059 (manufacturer: General Electric) and SLM-55067 (manufacturer: Wacker).
  • Particularly preferred agents according to the invention are characterized in that they contain at least one amino-functional silicone of the formula (Si 3-a)
  • m and n are numbers whose sum (m + n) is between 1 and 2000, preferably between 50 and 150, where n preferably values of 0 to 1999 and in particular of 49 to 149 and m preferably values of 1 to 2000 , in particular from 1 to 10 assumes.
  • These silicones are referred to as trimethylsilylamodimethicones according to the INCI declaration and are available, for example, under the name Q2-7224 (manufacturer: Dow Corning, a stabilized trimethylsilylamodimethicone).
  • compositions according to the invention which contain at least one amino-functional silicone of the formula (Si-3b)
  • R is -OH, (optionally ethoxylated and / or propoxylated) (C 1 to C 20 ) -
  • R ' is -OH, a (C 1 to C 2 o) alkoxy group or a -CH 3 group and m, n1 and n2 are numbers whose sum (m + n1 + n2) is between 1 and 2,000, preferably between 50 and 150, wherein the sum (n1 + n2) preferably takes values from 0 to 1999 and in particular from 49 to 149 and m preferably values from 1 to 2000, in particular from 1 to 10.
  • silicones are according to the INCI declaration as amodimethicone, or as functionalized
  • Amodimethicones such as bis (C13-15 alkoxy) PG amodimethicones (for example as
  • cosmetic preparations according to the invention which contain an amino-functional silicone whose amine number is above 0.25 meq / g, preferably above 0.3 meq / g and in particular above 0.4 meq / g lies.
  • the amine number stands for the milliequivalents
  • Amine per gram of amino-functional silicone It can be determined by titration and also expressed in mg KOH / g.
  • amino-functional silicones which are terminated by terminal amino groups, which in turn are particularly preferably quaternary. Excellent for this are diquarternary silicones.
  • Suitable diquaternary silicones are selected from compounds of the general formula (Si3c)
  • At least one of the radicals has at least 8 carbon atoms and the other radicals have 1 to 4 carbon atoms
  • the radicals R 7 to R 12 are identical or different and independently of one another and are C 1 - to C 10 -alkyl or phenyl,
  • A is a divalent organic linking group
  • n is a number from 0 to 200, preferably from 10 to 120, particularly preferably from 10 to 40, and
  • the divalent linking group is preferably a C1 to C12 alkylene or
  • Alkoxyalkylene group which may be substituted with one or more hydroxyl groups.
  • the anion X ' can be a halide ion, an acetate, an organic carboxylate or a
  • a preferred diquaternary silicone has the general formula (Si3d)
  • R is an alkyl radical having at least 8 C atoms and n is a number from 10 to 120.
  • Suitable silicone polymers having two terminal quaternary ammonium groups are known under the INCI name Quaternium-80. These are dimethylsiloxanes with two terminal trialkylammonium groups. Such diquaternary polydimethylsiloxanes are marketed by Evonik under the trade names Abil ® Quat 3270, 3272 and 3474th
  • Cosmetic or dermatological preparations preferred according to the invention are characterized in that, based on their weight, they contain 0.01 to 10% by weight, preferably 0.01 to 8% by weight, particularly preferably 0.1 to 7.5% by weight and in particular from 0.2 to 5% by weight of amino-functional silicone (s) and / or diquaternary silicone.
  • the amodimethicones it is also possible for the amodimethicones to form a separate phase in the compositions according to the invention.
  • the amount of amodimethicone may be up to 40% by weight, preferably in amounts of up to 25% by weight, based on the total composition.
  • polyammonium polysiloxane compounds may be obtained for example under the trade name Baysilone® ® GE Bayer Silicones.
  • Baysilone TP 3911, SME 253 and SFE 839 are preferred.
  • Very particular preference is given to the use of Baysilone TP 3911 as the active component of the compositions according to the invention.
  • the polyammonium-polysiloxane compounds are used in the compositions according to the invention in an amount of from 0.01 to 10% by weight, preferably from 0.01 to 7.5, particularly preferably from 0.01 to 5.0% by weight, very particularly preferably from 0 , 05 to 2.5 wt.% Each used in relation to the total composition.
  • cyclic dimethicones designated as cyclomethicones according to INCI are also preferably used according to the invention.
  • cosmetic or dermatological preparations according to the invention which contain at least one silicone of the formula (Si-4) in which x is a number from 3 to 200, preferably from 3 to 10, more preferably from 3 to 7 and in particular 3, 4, 5 or 6 stands.
  • water-soluble silicones can be present in the compositions according to the invention.
  • dimethicone copolyols according to the invention are, for example, those sold commercially under the trade names SILWET (Union Carbide Corporation) and DOW
  • dimethicone copolyols according to the invention are Dow Corning 190 and Dow
  • the Dimethiconcopolyole are in the compositions of the invention in amounts of
  • 0.01 to 10 wt.% Preferably 0.01 to 8 wt.%, Particularly preferably 0.1 to 7.5 wt.% And in particular 0.1 to 5 wt.% Of dimethicone copolyol based on the composition.
  • Dimethiconols form a further group of silicones which are particularly preferred according to the invention.
  • the dimethiconols according to the invention can be both linear and branched as well as cyclic or cyclic and branched.
  • Linear dimethiconols can be represented by the following structural formula (Si8-I):
  • Branched dimethiconols can be represented by the structural formula (Si8 - II):
  • the radicals R 1 and R 2 are each independently hydrogen, a methyl radical, a C 2 to C 30 linear, saturated or unsaturated hydrocarbon radical, a phenyl radical and / or an aryl radical.
  • the groups represented by R 1 and R 2 include alkyl groups such as methyl, ethyl, propyl, isopropyl, butyl, isobutyl, pentyl, isopentyl, neopentyl, amyl, isoamyl, hexyl, isohexyl and the like; Alkenyl radicals such as vinyl, halovinyl, alkylvinyl, allyl, haloallyl, alkylallyl; Cycloalkyl radicals such as cyclobutyl, cyclopentyl, cyclohexyl and the like; Phenyl radicals, benzyl radicals, halohydrocarbon radicals, such as 3-chloropropyl,
  • R 1 examples include methylene, ethylene, propylene, hexamethylene, decamethylene, -CH 2 CH (CH 3 ) CH 2 -, phenylene, naphthylene, -CH 2 CH 2 SCH 2 CH 2 -, -CH 2 CH 2 OCH 2 - , -OCH 2 CH 2 -, -OCH 2 CH 2 CH 2 -, -CH 2 CH (CH 3 ) C (O) OCH 2 -, - (CHz) 3 CC (O) OCH 2 CH 2 -, -C 6 H 4 C 6 H 4 -, -C 6 H 4 CH 2 C 6 H 4 -; and - (CH 2 ) 3 C (O) SCH 2 CH 2 -.
  • R 1 and R 2 are methyl, phenyl and C 2 to C 22 alkyl radicals. Of the C2 to C22 alkyl radicals, lauryl, stearyl and behenyl radicals are particularly preferred.
  • the numbers x, y and z are integers and each run independently from 0 to 50,000.
  • the molecular weights of the dimethiconols are between 1,000 D and 10000000 D.
  • the viscosities are between 100 and 10,000,000 cPs measured at 25 0 C by means of a glass capillary viscometer according to Dow Corning Corporate Test Method CTM 0004 dated 20 July 1970. Preferred viscosities are from 1000 to 5,000,000 cPs, most preferred viscosities are between 10,000 and 3,000,000 cps. The most preferred range is between 50,000 and 2,000,000 cps.
  • Examples of such products include the following commercial products: Botanisil NU-150M (Botanigenics), Dow Coming 1-1254 Fluid, Dow Corning 2-9023 Fluid, Dow Corning 2-9026 Fluid, Ultrapure Dimethiconol (Ultra Chemical), Unisil SF- R (Universal Preserve), X-21-5619 (Shin-Etsu Chemical Co.), Abil OSW 5 (Degussa Care Speciales), ACC DL-9430 Emulsion (Taylor Chemical Company), AEC Dimethiconol & Sodium Dodecylbenzenesulfonate (A & E Connock (Perfumery & Cosmetics) Ltd.), BC Dimethiconol Emulsion 95 (Basildon Chemical Company, Ltd.), Cosmetic Fluid 1401, Cosmetic Fluid 1403, Cosmetic Fluid 1501, Cosmetic Fluid 1401 DC (all aforementioned Chemsil Silicones, Inc.), Dow Corning 1401 Fluid, Dow Corning 1403 Fluid, Dow Corning 1501 Fluid, Dow Corning 1784 H
  • the dimethiconols (Si8) are present in the compositions according to the invention in amounts of from 0.01 to 10% by weight, preferably from 0.01 to 8% by weight, more preferably from 0.1 to 7.5% by weight and in particular from 0.1 to 5% by weight of dimethiconol based on the composition.
  • the teaching of the invention also includes that a mixture of several ingredients b) from the different classes mentioned, at least two different classes can be used in the compositions of the invention.
  • a cosmetic oil can be used.
  • these oil bodies defined below have a melting point of less than 50 0 C, more preferably less than 45 0 C, most preferably less than 40 0 C, most preferably less than 35 0 C and most preferably the cosmetic oils are smaller at a temperature as 30 0 C flowable.
  • these oils are defined and described in more detail.
  • natural and synthetic cosmetic oils include: vegetable oils. Examples of such oils are sunflower oil, olive oil, soybean oil, rapeseed oil, almond oil, jojoba oil, orange oil, wheat germ oil, peach kernel oil and the liquid portions of coconut oil.
  • Ester oils are to be understood as meaning the esters of C 6 - C 30 fatty acids with C 2 - C 30 fatty alcohols. The monoesters of the fatty acids with alcohols having 2 to 24 carbon atoms are preferred.
  • fatty acid components used in the esters are caproic, caprylic, 2-ethylhexanoic, capric, lauric, isotridecanoic, myristic, palmitic, palmitoleic, stearic, isostearic, oleic, elaidic, petroselic, linoleic, linolenic Behenic acid and erucic acid.
  • fatty alcohol components in the ester oils are isopropyl alcohol, caproic alcohol, capryl alcohol, 2-ethylhexyl alcohol, capric alcohol, lauryl alcohol, isotridecyl alcohol, myristyl alcohol, cetyl alcohol, palmoleyl alcohol, stearyl alcohol, isostearyl alcohol, oleyl alcohol, elaidyl alcohol, petroselinyl alcohol, linolyl alcohol, linolenyl alcohol, elaeostearyl alcohol, arachyl alcohol, Gadoleyl alcohol, behenyl alcohol, erucyl alcohol and brassidyl alcohol.
  • isopropyl myristate IPM Rilanit ®
  • isononanoic acid C16-18 alkyl ester Cetiol ® SN
  • 2-ethylhexyl palmitate Cegesoft ® 24
  • stearic acid-2-ethylhexyl ester Cetiol ® 868
  • cetyl oleate glycerol tricaprylate
  • Kokosfettalkohol- caprate / caprylate Cetiol ® LC
  • n-butyl stearate Oleyl erucate
  • isopropyl palmitate IPP Rilanit ®
  • Oleyl Oleate Cetiol ®
  • Laurate (Cetiol ® A), di-n-butyl adipate (Cetiol ® B), myristyl myristate (Cetiol ® MM),
  • Cetearyl Isononanoate (Cetiol ® SN), decyl oleate (Cetiol ® V).
  • Dicarboxylic acid esters such as di-n-butyl adipate, di- (2-ethylhexyl) adipate, di- (2-ethylhexyl) succinate and di-isotridecyl acelate
  • diol esters such as ethylene glycol dioleate, ethylene glycol diisotridecanoate, propylene glycol di (2- ethylhexanoate), propylene glycol diisostearate,
  • Glycerol carbonate or dicaprylyl carbonate (Cetiol ® CC)
  • Fatty acid partial glycerides which are monoglycerides, diglycerides and their technical
  • the partial glycerides preferably follow the
  • R 3 in the R 1 , R 2 and R 3 is independently of one another hydrogen or a linear or branched, saturated and / or unsaturated acyl radical having 6 to 22, preferably 12 to 18, Carbon atoms are provided with the proviso that at least one of these groups is an acyl radical and at least one of these groups is hydrogen.
  • the sum (m + n + q) is 0 or numbers from 1 to 100, preferably 0 or 5 to 25.
  • R 1 is an acyl radical and R 2 and R 3 are hydrogen and the sum (m + n + q) is 0.
  • Typical examples are mono- and / or diglycerides based on caproic, caprylic, 2-ethylhexanoic, capric, lauric, isotridecanoic, myristic, palmitic, palmitic, stearic, isostearic, oleic, elaidic, petroselic, linoleic , Linolenic acid, elaeostearic acid, arachidic acid, gadoleic acid, behenic acid and erucic acid.
  • oleic acid monoglycerides are used.
  • Natural oils include, for example, amaranth seed oil, apricot kernel oil, argan oil, avocado oil, babassu oil, cottonseed oil, borage seed oil, camelina oil, thistle oil, peanut oil, pomegranate seed oil, grapefruit seed oil, hemp oil, hazelnut oil, elderflower seed oil, currant seed oil, jojoba oil, cocoa butter, linseed oil, macadamia nut oil, corn oil, almond oil, marula oil , Evening primrose oil, olive oil, palm oil, rapeseed oil, rice oil, sea buckthorn fruit oil, sea buckthorn seed oil, sesame oil, shea butter, soybean oil, sunflower oil, grapeseed oil, walnut oil or wild rose oil.
  • the agents contain at least one surface-active substance, with both anionic and zwitterionic, ampholytic, nonionic and cationic surface-active substances being suitable in principle.
  • the choice of surfactants depends on the nature of the agent.
  • at least one surfactant is selected from the group of anionic, zwitterionic or nonionic surface-active substances. It is preferred here that at least one anionic and at least one zwitterionic surface-active substance is chosen.
  • These surface-active substances are particularly preferably selected from the group of particularly mild surface-active substances. In many cases, however, it has proved to be advantageous to select the surfactants from anionic, zwitterionic or nonionic surfactants.
  • the ratio between anionic and zwitterionic surface-active substances is between 10: 1 and 1: 5.
  • the ratio is particularly preferably 5: 1 to 1: 2.
  • Suitable anionic surfactants (tanion) in preparations according to the invention are all suitable for use on the human body suitable anionic surfactants.
  • mild anionic surfactants are used as anionic surfactants.
  • the following anionic surfactants are particularly preferred according to the invention: acyl lactylates,
  • Acyl isethionates having 8 to 24 carbon atoms in the acyl group are long known, skin-friendly surfactants, which are accessible by esterification of fatty acids with the sodium salt of 2-hydroxyethane-sulfonic acid (isethionic acid). If you for this esterification fatty acids with 8 to 24 carbon atoms, ie z.
  • Sulfobernsteinklado- and dialkyl esters having 8 to 24 carbon atoms in the alkyl group and sulfosuccinic monoalkylpolyoxyethylester having 8 to 24 carbon atoms in the alkyl group and 1 to 6 oxyethyl groups.
  • the Sulfobernsteinklamonoalkyl (C 8 -C 24 ) ester dinatrium salts are prepared by known methods z. B. prepared by reacting maleic anhydride with a fatty alcohol having 8 - 24 carbon atoms to maleic acid monoester of the fatty alcohol and sulfites this with sodium sulfite to Sulfobernsteinklaester.
  • Particularly suitable sulfosuccinic acid esters are derived from fatty alcohol fractions having 12- 18 C atoms, as z. B. from coconut oil or Kokosfettkladester are accessible by hydrogenation.
  • Alkylpolyglykolethersulfate of the formula RO (CH 2 -CH 2 O) x -OSO 3 H, in which R is a preferably linear alkyl group having 8 to 30 carbon atoms and x 0 or 1 to 12,
  • Esters of tartaric acid and citric acid with alcohols which are adducts of about 2-15 molecules of ethylene oxide and / or propylene oxide with fatty alcohols having 8 to 22 C atoms,
  • R 1 (OCH 2 CH 2 ) n -O- (PO-OX) -OR 2 , in which R 1 is preferably an aliphatic hydrocarbon radical having 8 to 30 carbon atoms, R 2 is hydrogen, a radical (CH 2 CH 2 O ) n R 2 or X, n is from 1 to 10 and X is hydrogen, an alkali or alkaline earth metal or NR 3 R 4 R 5 R 6 , with R 3 to R 6 independently of one another represent hydrogen or a Ci to C 4 - hydrocarbon radical,
  • Typical examples of monoglyceride (ether) sulfates suitable for the purposes of the invention are the reaction products of lauric acid monoglyceride, coconut fatty acid monoglyceride, palmitic acid monoglyceride, stearic acid monoglyceride, oleic acid monoglyceride and tallow fatty acid monoglyceride and their ethylene oxide adducts with sulfur trioxide or chlorosulfonic acid in the form of their sodium salts.
  • RCO is a linear acyl radical having 8 to 18 carbon atoms, amide ether carboxylic acids, R 1 -CO-NR 2 -CH 2 CH 2 -O- (CH 2 CH 2 O) n CH 2 COOM, with R 1 is a straight-chain or branched alkyl or alkenyl radical having a number of carbon atoms in the chain of 2 to 30, n is an integer from 1 to 20 and R 2 is hydrogen, a methyl, ethyl, propyl, isopropyl -, n-butyl, t-butyl or iso-butyl radical and M is hydrogen or a metal such as alkali metal, in particular sodium, potassium, lithium, alkaline earth metal, in particular magnesium, calcium, zinc, or an ammonium ion, such as + NR 3 R 4 R 5 R 6 , with R 3 to R 6 independently of one another represent hydrogen or a C 1 to C 4 hydro
  • Condensation products of a water-soluble salt of a water-soluble protein hydrolyzate with a suitable C8 - C30 fatty acid derivative, for example a fatty acid halide Such products have long been commercially available under the trademark Lamepon® ®, Maypon ®, Gluadin® ®, Hostapon® ® KCG or Amisoft ®, glutamates and aspartates.
  • the mild anionic surfactants contain polyglycol ether chains, it is particularly preferred that they have a narrow homolog distribution. Also, in the case of mild anionic surfactants having polyglycol ether units, it is preferred that the number of glycol ether groups is 1 to 20, preferably 2 to 15, more preferably 2 to 12.
  • Particularly mild anionic surfactants having polyglycol ether without restricted homologue distribution may for example be obtained even if the one hand, the number of polyglycol ether amounts to 4 to 12 and are chosen as a counter ion Zn or Mg ions. Examples of these are the commercial product Texapon ASV ®.
  • Zwitterionic surfactants are those surface-active compounds which carry in the molecule at least one quaternary ammonium group and at least one -COO () or -SO 3 () group.
  • Particularly suitable zwitterionic surfactants are the so-called betaines such as N-alkyl-N, N-dimethylammonium glycinates, for example cocoalkyldimethylammonium glycinate, N-acylaminopropyl N, N-dimethylammonium glycinates, for example cocoacylaminopropyldimethylammonium glycinate, and Alkyl-3-carboxymethyl-3-hydroxyethyl-imidazolines each having 8 to 18 carbon atoms in the alkyl or acyl group and Kokosacylaminoethylhydroxyethylcarboxymethylglycinat.
  • a preferred zwitterionic surfactant is the fatty acid amide derivative known by the INCI name Coca
  • Ampholytic surfactants are understood as meaning those surface-active compounds which contain, in addition to a C 8 -C 2 -alkyl or -acyl group in the molecule, at least one free amino group and at least one -COOH or -SO 3 H group and for the formation of internal Salts are capable.
  • ampholytic surfactants are N-alkylglycines, N-alkylpropionic acids, N-alkylaminobutyric acids, N-alkyliminodipropionic acids, N-hydroxyethyl-N-alkylamidopropylglycines, N-alkyltaurines, N-alkylsarcosines, 2-alkylaminopropionic acids and alkylaminoacetic acids each having about 8 to 24 C Atoms in the alkyl group.
  • amphoteric or zwitterionic surfactants are alkylbetaines, alkylamidobetaines, aminopropionates, aminoglycinates, imidazolinium betaines and sulfobetaines.
  • ampholytic surfactants are N-cocoalkylaminopropionate, cocoacylaminoethylaminopropionate and C 12 -C 18 -acylsarcosine.
  • Nonionic surfactants contain as hydrophilic group e.g. a polyol group, a polyalkylene glycol ether group, or a combination of polyol and polyglycol ether groups.
  • hydrophilic group e.g. a polyol group, a polyalkylene glycol ether group, or a combination of polyol and polyglycol ether groups.
  • Such compounds are, for example
  • Sugar surfactants of the fatty acid N-alkylpolyhydroxyalkylamide type a nonionic surfactant of the formula (Tnio-3), R 5 CO-NR 6 - [Z] (Tnio-3) in the R 5 CO for an aliphatic acyl radical having 6 to 22 carbon atoms, R 6 is hydrogen, an alkyl or hydroxyalkyl radical having 1 to 4 carbon atoms and [Z] a linear or branched polyhydroxyalkyl having 3 to 12 carbon atoms and 3 to 10 hydroxyl groups.
  • a very particularly preferred embodiment additionally contains at least one further cationic compound in addition to the obligatory ingredients.
  • This cationic compound can be a cationic surfactant and / or a cationic polymer or at least one cationic surfactant and one cationic polymer.
  • Cationic in the sense of the invention in this embodiment is also to be understood as an amphoteric polymer.
  • amphoteric polymer For the description and definition of both the other cationic surfactants and the cationic and / or amphoteric polymers will be discussed in the following description at a given place.
  • quaternary ammonium compounds are ammonium halides, especially chlorides and bromides, such as alkyltrimethylammonium chlorides, dialkyldimethylammonium chlorides and trialkylmethylammonium chlorides, e.g. Cetyltrimethylammonium chloride, stearyltrimethylammonium chloride, distearyldimethylammonium chloride, lauryldimethylammonium chloride, lauryldimethylbenzylammonium chloride and tricetylmethylammonium chloride, as well as the imidazolium compounds known under the INCI names Quaternium-27 and Quaternium-83.
  • cationic compounds containing behenyl radicals in particular the substances known as behentrimonium chloride or bromide (docosanyltrimethylammonium chloride or bromide), are particularly preferably usable.
  • behentrimonium chloride or bromide docosanyltrimethylammonium chloride or bromide
  • Other preferred quaternary ammonium compounds have at least two behenyl residues.
  • Genamin ® KDMP (Clariant).
  • Esterquats are known substances. Such products are marketed under the trade names Stepantex® ®, ® and Dehyquart® Armocare® ®.
  • the products Armocare ® VGH-70, a N, N-bis (2-palmitoyloxyethyl) dimethylammonium chloride, as well as Dehyquart ® F-75, Dehyquart ® C-4046, Dehyquart ® L80 and Dehyquart ® AU-35 are examples of such esterquats
  • the cationic surfactants of the present invention are also understood to mean cationic compounds of the following general structure: RCO-XN + R 1 R 2 R 3 R 4 A " (Tkat-2)
  • R here stands for a substituted or unsubstituted, branched or straight-chain alkyl or alkenyl radical having 11 to 35 carbon atoms in the chain
  • X is -O- or -NR 5 -
  • R 1 represents an alkylene group having 2 to 6 C atoms, which may be unsubstituted or substituted, in which case substitution with an -OH or -NH group is preferred in the case of a substitution
  • R 2 , R 3 and R 4 each independently represent an alkyl or hydroxyalkyl group having 1 to 6 C atoms in the chain, which chain may be straight or branched.
  • radicals according to the invention are methyl, ethyl, propyl, isopropyl, butyl, isobutyl, tert-butyl, pentyl, isopentyl, neopentyl, hexyl, iso-hexyl, hydroxyalkyl, dihydroxyalkyl, hydroxyethyl, hydroxypropyl, dihydroxypropyl , Hydroxybutyl, dihydroxybutyl, trihydroxybutyl, trihydroxypropyl, dihydroxyethyl,
  • R5 is hydrogen or a C1 to C6 straight-chain or branched, alkyl or alkenyl radical which may also be substituted by a hydroxyl group, especially methyl, ethyl, propyl, isopropyl, butyl, isobutyl, tert-butyl, pentyl, iso-pentyl, neo-pentyl, hexyl, iso -hexyl, hydroxyethyl, hydroxypropyl, dihydroxypropyl, hydroxybutyl, dihydroxybutyl, trihydroxybutyl, trihydroxypropyl, dihydroxyethyl and
  • a ' represents a halide such as fluoride, chloride or bromide, an alkyl sulfate such as a methosulfate or ethosulfate, a phosphate, a citrate, tartrate, maleate or fumarate
  • the teaching of the invention also includes the recognition that mixtures of at least two cationic surfactants can be used.
  • the cationic surfactants are preferably selected from at least two different structural classes of cationic surfactants.
  • Tkat cationic surfactants
  • the cationic surfactants include in particular alkylamidoamines, quaternized amidoamines, esterquats, cationic
  • the surfactants (T) are used in amounts of 0.05-45% by weight, preferably 0.1-30% by weight and very particularly preferably 0.5-25% by weight, based on the total agent used according to the invention ,
  • Emulsifiers which can be used according to the invention are, for example
  • Glucosides mixtures of alkyl (oligo) and fatty alcohols for example, the commercially available product ® Montanov 68,
  • Sterols are understood to mean a group of steroids which have a hydroxyl group on C-atom 3 of the steroid skeleton and are isolated both from animal tissue (zoosterols) and from vegetable fats (phytosterols). Examples of zoosterols are cholesterol and lanosterol. Examples of suitable phytosterols are ergosterol, stigmasterol and sitosterol. Mushrooms and yeasts are also used to isolate sterols, the so-called mycosterols.
  • glucose phospholipids e.g. as lecithins or phosphatidylcholines from e.g. Egg yolk or plant seeds (e.g., soybeans) are understood.
  • Fatty acid esters of sugars and sugar alcohols such as sorbitol
  • Polyglycerols and polyglycerol derivatives such as polyglycerol poly-12-hydroxystearate (commercial product Dehymuls ® PGPH),
  • Linear and branched fatty acids with 8 to 30 C atoms and their Na, K, ammonium, Ca, Mg and Zn salts.
  • the agents according to the invention preferably contain the emulsifiers in amounts of 0.1-25% by weight, in particular 0.5-15% by weight, based on the total agent.
  • Very particularly cationic and / or amphoteric and / or zwitterionic polymers are used as further ingredients in the compositions according to the invention.
  • nonionic polymers are also considered.
  • Preferred cationic groups are quaternary ammonium groups. Especially such
  • Polymers in which the quaternary ammonium group is bonded via a C1-4-hydrocarbon group to a polymer main chain composed of acrylic acid, methacrylic acid or derivatives thereof have proven to be particularly suitable.
  • Suitable polymers with quaternary amine groups are, for example, those in CTFA Cosmetic
  • Methylvinylimidazolium chloride / inylpyrrolidone copolymer (Polyquaternium-16) or quaternized vinylpyrrolidone / dimethylaminoethyl methacrylate copolymer (Polyquaternium-11).
  • a particularly suitable homopolymer is, if desired, crosslinked,
  • Suitable cationic polymers derived from natural polymers are cationic ones
  • Cationic polysaccharides have the general formula (P-3) GOB-N + R a R b R c X
  • G is an anhydroglucose residue, for example starch or cellulose anhydroglucose
  • B is a divalent linking group, for example alkylene, oxyalkylene, polyoxyalkylene or
  • R 3 , R b and R c are independently alkyl, aryl, alkylaryl, arylalkyl, alkoxyalkyl or
  • Alkoxyaryl each having up to 18 carbon atoms, wherein the total number of carbon atoms in R a , R b and R c is preferably not more than 20;
  • X ' is a common counter anion and is preferably chloride.
  • a cationic cellulose is sold under the name Polymer JR 400 from Amerchol ® and has the INCI designation Polyquaternium-10 degrees.
  • Another cationic cellulose bears the INCI name Polyquaternium-24 and is sold under the trade name Polymer LM-200 by Amerchol.
  • Other commercial products are the compounds Celquat ® H 100, Celquat ® L and 200. The commercial products mentioned are preferred cationic celluloses.
  • Suitable cationic guar derivatives are marketed under the trade name Jaguar ® and have the INCI name guar hydroxypropyltrimonium chloride. Further particularly suitable cationic guar derivatives are also used by the company.
  • Hercules under the name N-Hance ® commercially.
  • cationic guar derivatives are marketed by the company. Cognis under the name Cosmedia® ®.
  • a preferred cationic guar derivative is the commercial product AquaCat® ® from. Hercules. This raw material is an already pre-dissolved cationic guar derivative.
  • Other preferred cationic polymers are, for example, quaternized cellulose derivatives, such as are available under the names of Celquat ® and Polymer JR ® commercially.
  • the compounds Celquat ® H 100, Celquat ® L 200 and Polymer JR ® 400 are preferred quaternized cellulose derivatives, cationic alkyl polyglycosides, cationized honey, for example the commercial product Honeyquat ® 50, cationic guar derivatives, in particular under the trade name Cosmedia ® guar and Jaguar® products, polymeric dimethyldiallylammonium salts and their copolymers with esters and amides of acrylic acid and methacrylic acid.
  • Such compounds are sold under the names Gafquat ® 734 and Gafquat ® 755 commercially,
  • Vinylpyrrolidone-vinyl imidazolium copolymers such as those offered under the names Luviquat ® FC 370, FC 550, FC 905 and HM 552, quaternized polyvinyl alcohol, as well as by the names of Polyquaternium 2, Polyquaternium 17, Polyquaternium 18 and Polyquaternium 27, having quaternary Nitrogen atoms in the polymer backbone,
  • Vinylpyrrolidone-vinylcaprolactam-acrylate terpolymers such as those offered with acrylic acid esters and acrylamides as the third monomer building commercially, for example, under the name Aquaflex ® SF 40.
  • Can be used as cationic polymers are sold under the names Polyquaternium-24 (commercial product z. B. Quatrisoft ® LM 200), known polymers.
  • Gaffix ® VC 713 manufactured by ISP:
  • the copolymers of vinylpyrrolidone such as the commercial products Copolymer 845 (ISP manufacturer) are Gafquat ® ASCP 1011, Gafquat ® HS 110, Luviquat ® 8155 and Luviquat ® MS 370 available are.
  • preferred cationic polymers are cationic cellulose derivatives and chitosan and its derivatives, in particular the commercial products Polymer ® JR 400, Hydagen ® HCMF and Kytamer ® PC, cationic guar derivatives, cationic honey derivatives, in particular the commercial product Honeyquat ® 50 and polymers Type Polyquaternium-37.
  • cationized protein hydrolysates are to be counted among the cationic polymers, wherein the underlying protein hydrolyzate from the animal, for example from collagen, milk or Keratin, from the plant, for example, from wheat, corn, rice, potatoes, soy or almonds, marine life forms, such as fish collagen or algae, or biotechnologically derived protein hydrolysates, may originate.
  • the cationic protein hydrolysates and derivatives according to the invention those mentioned under the INCI names in the "International Cosmetic Ingredient Dictionary and Handbook", (seventh edition 1997, The Cosmetic, Toiletry, and Fragrance Association 1101 17 th Street, NW, Suite 300 Washington, DC 20036-4702) and commercially available products.
  • the cationic polymers are preferably contained in the compositions according to the invention in amounts of from 0.05 to 10% by weight, based on the total agent. Amounts of 0.1 to 5 wt .-% are particularly preferred.
  • Amphoteric polymers as well as the cationic polymers, are most preferred
  • Copolymers of diallyldimethylammonium chloride and acrylic acid are under the INCI name Polyquaternium-22, inter alia, with the trade name
  • amphoteric polymers are terpolymers of diallyldimethylammonium chloride, acrylamide and acrylic acid. These copolymers are sold under the INCI name Polyquaternium-39, among others, with the trade name Merquat ®
  • amphoteric polymers are preferably contained in the agents according to the invention in amounts of from 0.05 to 10% by weight, based on the total agent. Amounts of 0.1 to 5 wt .-% are particularly preferred.
  • agents according to the invention can be nonionic
  • Suitable nonionic polymers are, for example:
  • Vinylpyrrolidon ⁇ ynyl ester copolymers such as for example, under the trade name Luviskol ® (BASF) /.
  • Luviskol ® VA 64 and Luviskol ® VA 73, each vinylpyrrolidone / vinyl acetate copolymers are also preferred nonionic polymers.
  • Cellulose ethers such as hydroxypropyl cellulose, hydroxyethyl cellulose and hydroxypropylcellulose Methylhy-, as sold for example under the trademark Culminal® ® and Benecel ® (AQUALON) and Natrosol ® grades (Hercules).
  • Starch and its derivatives in particular starch, such as Structure XL ® (National Starch), a multifunctional, salt-tolerant starch; shellac Polyvinylpyrrolidones, as sold for example under the name Luviskol ® (BASF).
  • starch such as Structure XL ® (National Starch), a multifunctional, salt-tolerant starch; shellac Polyvinylpyrrolidones, as sold for example under the name Luviskol ® (BASF).
  • the nonionic polymers are preferably contained in the compositions according to the invention in amounts of from 0.05 to 10% by weight, based on the total agent. Amounts of 0.1 to 5 wt .-% are particularly preferred.
  • the polymers (P) are preferably present in the compositions used according to the invention in amounts of from 0.01 to 30% by weight, based on the total composition. Amounts of from 0.01 to 25, in particular from 0.01 to 15 wt .-%, are particularly preferred.
  • compositions according to the invention contain fatty substances (fat) as further active ingredient.
  • Fat substances are understood to mean fatty acids, fatty alcohols, natural and synthetic waxes, which can be in solid form as well as liquid in aqueous dispersion, and natural and synthetic cosmetic oil components.
  • fatty acids can be used linear and / or branched, saturated and / or unsaturated fatty acids having 6 to 30 carbon atoms. Preference is given to fatty acids having 10 to 22 carbon atoms. Among these could be mentioned, for example, isostearic as the commercial products Emersol ® 871 and Emersol ® 875, and isopalmitic acids such as the commercial product Edenor ® IP 95, and all other products sold under the trade names Edenor ® (Cognis) fatty acids.
  • fatty acids are caproic, caprylic, 2-ethylhexanoic, capric, lauric, isotridecanoic, myristic, palmitic, palmitoleic, stearic, isostearic, oleic, elaidic, petroselic, linoleic, linoleic and erucic acid and mixtures thereof.
  • Particularly preferred are usually the fatty acid cuttings obtainable from coconut oil or palm oil; In particular, the use of stearic acid is usually preferred.
  • the amount used is 0.1 - 15 wt.%, Based on the total mean.
  • the amount is preferably 0.5-10% by weight, with amounts of 1-5% by weight being particularly advantageous.
  • Fatty alcohols may be used are saturated, mono- or polyunsaturated, branched or unbranched fatty alcohols with C 6 - C 30 -, preferably C 0 - C 22 - and particularly preferably C 2 - C 22 - carbon atoms.
  • Decanol, octanol, dodecadienol, decadienol, oleyl alcohol, eruca alcohol, ricinol alcohol, stearyl alcohol, isostearyl alcohol, cetyl alcohol, lauryl alcohol, myristyl alcohol, arachidyl alcohol, capryl alcohol, capric alcohol, can be used for the purposes of the invention.
  • Linoleylalkohol, linolenyl alcohol and behenyl alcohol, and their Guerbet alcohols should have exemplary and non-limiting character.
  • the fatty alcohols are derived from preferably natural fatty acids. Also usable according to the invention are those fatty alcohol cuts which represent a mixture of different fatty alcohols.
  • Such substances are, for example, under the names Stenol ® such as Stenol ® 1618 or Lanette ® such as Lanette ® O or Lorol ®, for example, Lorol ® C8, Lorol C14 ®, Lorol C18 ®, ® Lorol C8-18, HD-Ocenol ®, Crodacol ® such as Crodacol ® CS, Novol ®, Eutanol ® G, Guerbitol ® 16, Guerbitol ® 18, Guerbitol ® 20, Isofol ® 12, Isofol ® 16, lsofol ® 24, Isofol ® 36, Isocarb ® 12, Isocarb ® 16 or acquire Isocarb® ® 24 for sale.
  • Stenol ® such as Stenol ® 1618 or Lanette ® such as Lanette ® O or Lorol ®
  • Lorol ® C8 Lorol C8-18
  • wool wax alcohols as are commercially available, for example under the names of Corona ®, White Swan ®, Coronet ® or Fluilan ® can be used according to the invention.
  • the fatty alcohols are used in amounts of from 0.1 to 30% by weight, based on the total preparation, preferably in amounts of from 0.1 to 20% by weight.
  • waxes As natural or synthetic waxes (Fatwax), solid paraffins or isoparaffins, carnauba waxes, beeswaxes, candelilla waxes, ozokerites, ceresin, spermaceti, sunflower wax, fruit waxes such as apple wax or citrus wax, microwaxes of PE or PP can be used according to the invention.
  • Such waxes are available, for example, from Kahl & Co., Trittau.
  • the amount used is 0.1-50 wt.% Based on the total agent, preferably 0.1 to 20 wt.% And particularly preferably 0.1 to 15 wt.% Based on the total agent.
  • the total amount of oil and fat components in the compositions according to the invention is usually 0.5-75% by weight, based on the total agent. Amounts of 0.5-35 wt .-% are preferred according to the invention.
  • compositions with the active substance complex according to the invention are protein hydrolysates and / or its derivatives (P).
  • protein hydrolysates of both vegetable and animal or marine or synthetic origin can be used.
  • Animal protein hydrolysates are, for example, elastin, collagen, keratin, silk and milk protein protein hydrolysates, which may also be present in the form of salts.
  • Such products are, for example, under the trademarks Dehylan ® (Cognis), Promois ® (Interorgana)
  • Lexein ® Inolex
  • kerasol tm ® (Croda) sold.
  • Plant proteins and their hydrolysates are, for example, products based on wheat,
  • Gluadin ® (Cognis), diamine ® (Diamalt) ® (Inolex), Hydrosoy ® (Croda) Hydro Lupine ® (Croda), hydro Sesame ® (Croda), Hydro tritium ® (Croda) and Crotein ® (Croda) and Puricare ® LS 9658 (Cognis) available.
  • protein hydrolysates according to the invention are of maritime origin. These include, for example, collagen hydrolyzates of fish or algae as well as protein hydrolysates of mussels or pearl hydrolyzates.
  • the protein hydrolysates (P) are present in the compositions in concentrations of 0.001% by weight to 20% by weight, preferably from 0.05% by weight to 15% by weight and most preferably in amounts of 0.05% by weight. up to 5% by weight.
  • compositions according to the invention can be further increased by a 2-pyrrolidinone-5-carboxylic acid and its derivatives (J).
  • Another object of the invention is therefore the use of derivatives of 2-pyrrolidinone-5-carboxylic acid.
  • Preference is given to the sodium, potassium, calcium, magnesium or ammonium salts in which the ammonium ion carries, in addition to hydrogen, one to three C 1 - to C 4 -alkyl groups.
  • the sodium salt is most preferred.
  • the amounts used in the inventive compositions are 0.05 to 10 wt.%, Based on the total agent, particularly preferably 0.1 to 5, and in particular 0.1 to 3 wt.%.
  • vitamins are vitamins, provitamins or vitamin precursors.
  • Vitamins, pro-vitamins and vitamin precursors are particularly preferred, which are assigned to the groups A, B, C, E, F and H.
  • the group of substances called vitamin A includes retinol (vitamin A 1 ) and 3,4-didehydroretinol (vitamin A 2 ).
  • the ß-carotene is the provitamin of retinol.
  • vitamin A component according to the invention for example, vitamin A acid and its esters, vitamin A aldehyde and vitamin A alcohol and its esters such as the palmitate and the acetate into consideration.
  • the agents according to the invention preferably contain the vitamin A component in amounts of 0.05-1% by weight, based on the total preparation.
  • the vitamin B group or the vitamin B complex include vitamin B 1 (thiamine) vitamin B 2 (riboflavin)
  • Vitamin B 3 the compounds nicotinic acid and nicotinamide (niacinamide) are often performed.
  • Preferred according to the invention is the nicotinic acid amide which is contained in the agents used according to the invention preferably in amounts of from 0.05 to 1% by weight, based on the total agent.
  • Vitamin B 5 pantothenic acid, panthenol and pantolactone. Panthenol and / or pantolactone are preferably used in the context of this group. Derivatives of panthenol which can be used according to the invention are, in particular, the esters and ethers of panthenol and also cationically derivatized panthenols. Individual representatives are for example the Panthenol triacetate, the panthenol monoethyl ether and its monoacetate, as well as cationic panthenol derivatives. The said compounds of the vitamin B 5 type are preferably contained in the agents according to the invention in amounts of 0.05-10% by weight, based on the total agent. Amounts of 0.1-5 wt .-% are particularly preferred. Vitamin B 6 (pyridoxine and pyridoxamine and pyridoxal).
  • Vitamin C (ascorbic acid). Vitamin C is used in the agents according to the invention preferably in amounts of 0.1 to 3 wt .-%, based on the total agent. Use in the form of palmitic acid ester, glucosides or phosphates may be preferred. The use in combination with tocopherols may also be preferred. Vitamin E (tocopherols, especially ⁇ -tocopherol). Tocopherol and its derivatives, which include in particular the esters such as the acetate, the nicotinate, the phosphate and the succinate, are preferably present in the agents according to the invention in amounts of 0.05-1% by weight, based on the total agent.
  • Vitamin F is usually understood as meaning essential fatty acids, in particular linoleic acid, linolenic acid and arachidonic acid.
  • Vitamin H is the compound (3aS, 4S, 6aR) -2-oxohexahydrothienol [3,4-d] - imidazole-4-valeric acid, for which, however, the trivial name biotin has meanwhile prevailed.
  • Biotin is preferably present in the compositions according to the invention in amounts of from 0.0001 to 1.0% by weight, in particular in amounts of from 0.001 to 0.01% by weight.
  • the compositions according to the invention preferably contain vitamins, provitamins and vitamin precursors from groups A, B, E and H. Panthenol, pantolactone, pyridoxine and its derivatives as well as nicotinic acid amide and biotin are particularly preferred.
  • Ayurvedic plants include Aegle Marmelos (Bilwa), Cyperus Rotundus (Nagar Motha), Emblica officinalis (Amalki), Morida Citrifolia (Ashyuka), Tinospora Cordifolia (Guduchi), Santalum album, (Chandana), Crocus sativus (Kumkuma), Cinnamonum Zeylanicum and Nelumbo Nucifera (Kamala).
  • the agents according to the invention may contain purine and / or derivative (s) of purine.
  • inventively preferred cosmetic agents characterized in that they - based on their weight - 0.001 to 2.5 wt .-%, preferably 0.0025 to 1 wt .-%, particularly preferably 0.005 to 0.5 wt .-% and in particular from 0.01 to 0.1% by weight of purine (s) and / or purine derivative (s).
  • the purines and the purine derivatives some representatives are particularly preferred according to the invention.
  • Cosmetic agents preferred according to the invention are characterized in that they contain purine one of the following compounds:
  • Caffeine has proved particularly useful in hair cosmetic formulations, for example in shampoos, conditioners, hair lotions and / or lotions, preferably in amounts of from 0.005 to 0.25% by weight, more preferably from 0.01 to 0.1% by weight and in particular from 0.01 to 0.05 wt .-% (in each case based on the composition) can be used.
  • taurine Another preferred active ingredient for additional use in the compositions of the invention is taurine, 2-aminoethanesulfonic acid and N-monomethyltaurine and N, N-dimethyltaurine.
  • Taurine derivatives are also understood to be taurins which occur naturally as metabolites in plant and / or animal and / or marine organisms. These include, for example, although not preferred, degradation products of cysteine, especially cysteine sulfinic acid.
  • taurine derivatives in the context of the present invention are the taurocholic acid and
  • agents according to the invention which - based on their weight - 0.0001 bis
  • wt .-% preferably 0.0005 to 5.0 wt .-%, particularly preferably 0.001 to 2.0 wt .-% and in particular 0.001 to 1, 0 wt .-% taurine and / or a derivative of the Taurines included.
  • compositions according to the invention contain penetration aids and / or swelling agents (M).
  • M penetration aids and / or swelling agents
  • These excipients provide better penetration of active ingredients into the keratin fiber or help swell the keratin fiber.
  • compositions of the invention preferably contain 0.01 to 5 wt .-% hydantoin or at least one Hydatoinderivates.
  • Hydantoin derivatives are particularly preferably used according to the invention, with 5-ureidohydantoin being particularly preferred.
  • hydantoin or hydantoin derivative (s) is / are used, amounts of from 0.02 to 2.5 wt .-% are very particularly preferred, from 0.05 to 1, 5 wt .-%, more preferably 0.075 to 1 wt .-% and in particular 0.1 to 0.25 wt .-% - each based on the total agent - most preferably.
  • the active ingredient is at least one
  • Polyhydroxy compound containing at least 2 OH groups are those having 2 to 12 OH groups, and especially those having 2, 3, 4, 5, 6 or 10
  • polyhydroxy compounds having 2 OH groups are also the polyethylene and polypropylene glycols.
  • the glycerin has a prominent one
  • compositions according to the invention are preferred in which the
  • Polyhydroxy compound is selected from ethylene glycol, propylene glycol, polyethylene glycol,
  • Polypropylene glycol Polypropylene glycol, glycerin, glucose, fructose, pentaerythritol, sorbitol, mannitol, xyNt and theirs
  • agents according to the invention are preferred which, based on the weight of the agent, are from 0.01 to 5
  • Wt.% Preferably 0.05 to 4 wt.%, Particularly preferably 0.05 to 3.5 wt.% And in particular 0.1 to 2.5 wt.% Polyhydroxy compound (s).
  • preservatives are the substance classes listed in Appendix 6, Parts A and B of the European Cosmetics Regulation. Particularly preferred is mild preservation, ideally without the addition of typical preservatives.
  • the agents according to the invention should additionally contain at least one UV light protection filter.
  • the high care effect of the agents according to the invention is of particular importance, in particular, since it gives excellent results even in the presence of oxidizing agents, for example in the context of oxidative hair dyeing.
  • a second subject of the invention is therefore a method for hair treatment, in which a cosmetic composition according to claim 1 is applied to the hair and rinsed after a contact time of the hair.
  • the exposure time is preferably a few seconds to 100 minutes, more preferably 1 to 50 minutes and most preferably 1 to 30 minutes.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Cosmetics (AREA)

Abstract

L'invention concerne des préparations cosmétiques, notamment des agents de conditionnement capillaire, contenant au moins un dérivé imidazoline pourvu d'au moins deux radicaux gras longs, et au moins une amine et/ou une amine cationisée.
PCT/EP2009/057038 2008-07-04 2009-06-08 Agents de conditionnement capillaire contenant des imidazolines WO2010000569A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP09772269A EP2340012A2 (fr) 2008-07-04 2009-06-08 Agents de conditionnement capillaire contenant des imidazolines

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE200810031715 DE102008031715A1 (de) 2008-07-04 2008-07-04 Haarkonditionierende Mittel mit Imidazolinen
DE102008031715.2 2008-07-04

Publications (2)

Publication Number Publication Date
WO2010000569A2 true WO2010000569A2 (fr) 2010-01-07
WO2010000569A3 WO2010000569A3 (fr) 2011-05-12

Family

ID=41119840

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2009/057038 WO2010000569A2 (fr) 2008-07-04 2009-06-08 Agents de conditionnement capillaire contenant des imidazolines

Country Status (3)

Country Link
EP (1) EP2340012A2 (fr)
DE (1) DE102008031715A1 (fr)
WO (1) WO2010000569A2 (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008099874A1 (fr) 2007-02-16 2008-08-21 Toyama Chemical Co., Ltd. Composition pharmaceutique comportant un dérivé de pyrazine et procédé d'utilisation d'un dérivé de pyrazine en combinaison
DE102011086218A1 (de) 2011-11-11 2013-05-16 Henkel Ag & Co. Kgaa Pflegende Haarbehandlungsmittel

Citations (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5393452A (en) * 1992-11-09 1995-02-28 General Electric Company 2 in 1 shampoo system and conditioner comprising a silicon-polyether copolymer
EP1093805A1 (fr) * 1999-10-20 2001-04-25 L'oreal Compositions cosmétiques contenant une émulsion d'un copolymère vinyldiméthicone/diméthicone et un tensioactif et leurs utilisations
WO2006012930A1 (fr) * 2004-07-30 2006-02-09 Henkel Kommanditgesellschaft Auf Aktien Revitalisants capillaires comprenant des imidazolines et des dimethiconols ou des silicones a fonction amino
JP2006169201A (ja) * 2004-12-20 2006-06-29 Mandom Corp パーマネントウェーブ前処理剤及び中間処理剤並びに該処理剤を用いた毛髪の処理方法
JP2006169202A (ja) * 2004-12-20 2006-06-29 Mandom Corp パーマネントウェーブ前処理剤及び中間処理剤並びに該処理剤を用いた毛髪の処理方法
US20060150344A1 (en) * 2003-08-13 2006-07-13 Burkhard Muller Method for smoothing fibers containing keratin
WO2007003307A1 (fr) * 2005-07-05 2007-01-11 Henkel Kommanditgesellschaft Auf Aktien Agents contenant de la l-carnitine, des derives de l-carnitine et au moins une autre substance
JP2007063198A (ja) * 2005-08-31 2007-03-15 Hoyu Co Ltd 毛髪化粧料
WO2008028777A1 (fr) * 2006-09-06 2008-03-13 Henkel Ag & Co. Kgaa Agents contenant des bioquinones et des hydrolysats de protéine
DE102007001027A1 (de) * 2007-01-02 2008-07-03 Henkel Kgaa Kosmetische Zusammensetzungen enthaltend ausgewählte Fettsäuren und Squalen
WO2009071408A1 (fr) * 2007-12-06 2009-06-11 Unilever Plc Composition de soin personnel
WO2009074463A2 (fr) * 2007-12-13 2009-06-18 Henkel Ag & Co. Kgaa Conditionneurs capillaires contenant des imidazolines et des silicones sélectionnées et/ou des huiles cosmétiques

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4237253A (en) 1977-04-21 1980-12-02 L'oreal Copolymers, their process of preparation, and cosmetic compounds containing them
US4122029A (en) 1977-07-27 1978-10-24 Dow Corning Corporation Emulsion compositions comprising a siloxane-oxyalkylene copolymer and an organic surfactant
US4265878A (en) 1979-06-07 1981-05-05 Dow Corning Corporation Antiperspirant stick compositions
JPS5699407A (en) 1980-01-09 1981-08-10 Kao Corp Hair rinse composition
US4393886A (en) 1980-09-05 1983-07-19 Ciba-Geigy Corporation Mixtures of quaternary, polymeric, high molecular weight ammonium salts, which are based on acrylic compounds, and surfactants, their preparation, and their use in cosmetics
JPS5813700A (ja) 1981-07-17 1983-01-26 花王株式会社 食器用洗浄剤組成物
US4421769A (en) 1981-09-29 1983-12-20 The Procter & Gamble Company Skin conditioning composition
DE3139438A1 (de) 1981-10-03 1983-04-21 Henkel KGaA, 4000 Düsseldorf Verwendung kolloidaler loesungen von seidenfibroin in haarkosmetischen mitteln und haarshampoo
EP0217274A3 (fr) 1985-09-30 1988-06-29 Kao Corporation Composition cosmétique pour les cheveux
DE3708451A1 (de) 1987-03-16 1988-10-06 Henkel Kgaa Zwitterionische polymere und deren verwendung in haarbehandlungsmitteln
DE3929973A1 (de) 1989-09-08 1991-03-14 Henkel Kgaa Haarpflegemittel
US5136093A (en) 1991-02-06 1992-08-04 Smith Ronald J Quaternized panthenol compounds and their use
DE4342560A1 (de) 1993-12-14 1995-06-22 Marbert Gmbh Ectoin und Ectoinderivate als Feuchtigkeitsspender in Kosmetikprodukten
DE4413686C2 (de) 1994-04-20 1996-10-24 Henkel Kgaa Kationische Zuckertenside, Verfahren zu ihrer Herstellung und deren Verwendung
KR960033321A (ko) 1995-03-06 1996-10-22 엠. 에이치. 크로이터ㆍ알. 스타이너 음료 또는 식물성 제제에 함유된 불필요한 친지성 오염물 및(또는) 잔류물의 제거 방법
GB9708182D0 (en) 1997-04-23 1997-06-11 Dow Corning Sa A method of making silicone in water emulsions
DE19738866A1 (de) 1997-09-05 1999-03-11 Henkel Kgaa Schaumarme Tensidmischungen mit Hydroxymischethern
DE19756454C1 (de) 1997-12-18 1999-06-17 Henkel Kgaa Verwendung von Glycerincarbonat
US5998537A (en) 1998-09-21 1999-12-07 Dow Corning Corporation Emulsions containing ultrahigh viscosity silicone polymers
FR2785183B1 (fr) 1998-11-04 2002-04-05 Oreal COMPOSITION TINCTORIALE CONTENANT UN COLORANT DIRECT CATIONIQUE ET UNE PYRAZOLO-[1,5-a]- PYRIMIDINE A TITRE DE BASE D'OXYDATION, ET PROCEDES DE TEINTURE
DE29908573U1 (de) 1999-05-14 1999-08-05 Wella Ag Haarfärbemittel
CA2423285C (fr) 2000-07-27 2009-12-22 Ge Bayer Silicones Gmbh & Co. Kg Composes de polyammonium-polysiloxane et procedes de preparation et d'utilisation desdits composes

Patent Citations (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5393452A (en) * 1992-11-09 1995-02-28 General Electric Company 2 in 1 shampoo system and conditioner comprising a silicon-polyether copolymer
EP1093805A1 (fr) * 1999-10-20 2001-04-25 L'oreal Compositions cosmétiques contenant une émulsion d'un copolymère vinyldiméthicone/diméthicone et un tensioactif et leurs utilisations
US20060150344A1 (en) * 2003-08-13 2006-07-13 Burkhard Muller Method for smoothing fibers containing keratin
WO2006012930A1 (fr) * 2004-07-30 2006-02-09 Henkel Kommanditgesellschaft Auf Aktien Revitalisants capillaires comprenant des imidazolines et des dimethiconols ou des silicones a fonction amino
JP2006169201A (ja) * 2004-12-20 2006-06-29 Mandom Corp パーマネントウェーブ前処理剤及び中間処理剤並びに該処理剤を用いた毛髪の処理方法
JP2006169202A (ja) * 2004-12-20 2006-06-29 Mandom Corp パーマネントウェーブ前処理剤及び中間処理剤並びに該処理剤を用いた毛髪の処理方法
WO2007003307A1 (fr) * 2005-07-05 2007-01-11 Henkel Kommanditgesellschaft Auf Aktien Agents contenant de la l-carnitine, des derives de l-carnitine et au moins une autre substance
JP2007063198A (ja) * 2005-08-31 2007-03-15 Hoyu Co Ltd 毛髪化粧料
WO2008028777A1 (fr) * 2006-09-06 2008-03-13 Henkel Ag & Co. Kgaa Agents contenant des bioquinones et des hydrolysats de protéine
DE102007001027A1 (de) * 2007-01-02 2008-07-03 Henkel Kgaa Kosmetische Zusammensetzungen enthaltend ausgewählte Fettsäuren und Squalen
WO2009071408A1 (fr) * 2007-12-06 2009-06-11 Unilever Plc Composition de soin personnel
WO2009074463A2 (fr) * 2007-12-13 2009-06-18 Henkel Ag & Co. Kgaa Conditionneurs capillaires contenant des imidazolines et des silicones sélectionnées et/ou des huiles cosmétiques

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008099874A1 (fr) 2007-02-16 2008-08-21 Toyama Chemical Co., Ltd. Composition pharmaceutique comportant un dérivé de pyrazine et procédé d'utilisation d'un dérivé de pyrazine en combinaison
DE102011086218A1 (de) 2011-11-11 2013-05-16 Henkel Ag & Co. Kgaa Pflegende Haarbehandlungsmittel
WO2013068172A2 (fr) 2011-11-11 2013-05-16 Henkel Ag & Co. Kgaa Produits de soins capillaires
WO2013068172A3 (fr) * 2011-11-11 2014-06-26 Henkel Ag & Co. Kgaa Produits de soins capillaires

Also Published As

Publication number Publication date
WO2010000569A3 (fr) 2011-05-12
DE102008031715A1 (de) 2010-01-07
EP2340012A2 (fr) 2011-07-06

Similar Documents

Publication Publication Date Title
WO2011009712A2 (fr) Produits de conditionnement capillaire contenant des silicones cationiques et de la diméthicone
WO2010018047A2 (fr) Composition cosmétique contenant des huiles issues des fruits du sumac
WO2011113501A1 (fr) Produits de soins capillaires contenant au moins quatre huiles sélectionnées
DE102010063923A1 (de) Haarbehandlungsmittel
DE102010063927A1 (de) Haarbehandlungsmittel
EP2593189A2 (fr) Compositions de conditionnement capillaire
EP2349195A2 (fr) Agents de conditionnement capillaire contenant des imidazolines
WO2011009710A2 (fr) Produits de conditionnement capillaire contenant des imidazolines cationiques et des silicones cationiques sélectionnées
DE102009044948A1 (de) Mittel zur Behandlung keratinischer Fasern enthaltend Dimethylsilanol Hyaluronate und Glycerin
WO2010000573A2 (fr) Agents de conditionnement capillaire contenant des imidazolines
EP2654701B1 (fr) Agents de traitement capillaire monophase ayant une teneur augmentée en silicone
WO2011018278A2 (fr) Compositions pour soins capillaires contenant de l’huile de ramboutan
EP2340011A2 (fr) Agents de conditionnement capillaire contenant des imidazolines
WO2010000569A2 (fr) Agents de conditionnement capillaire contenant des imidazolines
WO2010000582A2 (fr) Agents de conditionnement capillaire contenant des imidazolines
WO2011000698A2 (fr) Soin capillaire monophasique à teneur accrue en silicone
WO2010000632A2 (fr) Agents de conditionnement capillaire contenant des imidazolines
EP2705878A2 (fr) Cure capillaire à l'aide d'huiles d'esters sélectionnées, de silicones sélectionnés et de dérivés d'acide acrylique sélectionnés avec une faible teneur en eau
WO2011020646A2 (fr) Compositions de soin capillaire contenant de l'alcool lanolique à teneur élevée en alcools gras à longue chaîne
DE102009045997A1 (de) Haarbehandlungsmittel mit Polyquaternium-72
DE102009028537A1 (de) Zusammensetzungen zur Haarpflege enthaltend natürliche Öle mit hohen Anteilen gesättigter Fettsäuren
WO2010000658A2 (fr) Agents de conditionnement capillaire contenant des imidazolines
EP2335672A2 (fr) Soin capillaire sans silicone
WO2011009713A2 (fr) Composition cosmétique contenant de l'huile d'amarante éthoxylée
DE102009029196A1 (de) Haarbehandlungsmittel mit einem Campanulata Flower Extrakt

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 2009772269

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: DE